The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of 3- versus 5-day administration schedule of consolidation cytarabine in adults with acute myeloid leukemia (AML).
 
Kendall Diebold
No Relationships to Disclose
 
Kimo Bachiashvili
No Relationships to Disclose
 
Omer Hassan Jamy
No Relationships to Disclose
 
Pankit Vachhani
Consulting or Advisory Role - Abbvie; Amgen; Blueprint Medicines; CTI BioPharma Corp; Genentech/Roche; Incyte; MorphoSys; Novartis; Pfizer; Stemline Therapeutics
Speakers' Bureau - Incyte
Research Funding - Abbvie (Inst); Amgen (Inst); Astex Pharmaceuticals (Inst); Blueprint Medicines (Inst); Constellation Pharmaceuticals (Inst); CTI BioPharma Corp (Inst); Gilead/Forty Seven (Inst); Incyte (Inst); Kartos Therapeutics (Inst); Seagen (Inst); Takeda (Inst)
 
Kelly Nicole Godby
No Relationships to Disclose
 
Ravi Bhatia
No Relationships to Disclose
 
Barry Diamond
No Relationships to Disclose
 
Josh D Oliver
No Relationships to Disclose
 
Kaitlin R Moulton
No Relationships to Disclose
 
Sravanti Rangaraju
No Relationships to Disclose